Extension of Time to File SOU

BASILEA LABS

Basilea Pharmaceutica AG

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88056364
LAW OFFICE ASSIGNED LAW OFFICE 117
MARK SECTION
MARK BASILEA LABS (see, http://uspto.report/TM/88056364/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT BASILEA LABS
OWNER SECTION (current)
NAME Basilea Pharmaceutica AG
MAILING ADDRESS Grenzacherstrasse 487
CITY Basel
ZIP/POSTAL CODE 4058
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Switzerland
EMAIL XXXX
OWNER SECTION (proposed)
NAME Basilea Pharmaceutica AG
MAILING ADDRESS Grenzacherstrasse 487
CITY Basel
ZIP/POSTAL CODE 4058
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Switzerland
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Evan A. Raynes
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE eraynes@symbus.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) legalasst@symbus.com
CORRESPONDENCE INFORMATION (proposed)
NAME Evan A. Raynes
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE eraynes@symbus.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) kflanagan@symbus.com
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 001
CURRENT IDENTIFICATION Diagnostic preparations for clinical or medical laboratory use; Diagnostic reagents for clinical or medical laboratory use
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical and veterinary preparations for the treatment or prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary preparations for the treatment of infections caused by bacteria, fungi, viruses and rheumatoid arthritis; Pharmaceutical and veterinary preparations for the treatment of diseases, disorders and conditions in the area of oncology
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 3
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 09/03/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 2
SUBTOTAL AMOUNT [EXTENSION FEE] 250
TOTAL AMOUNT 250
SIGNATURE SECTION
SIGNATURE /Evan A. Raynes/
SIGNATORY'S NAME Evan A. Raynes
SIGNATORY'S POSITION Attorney of record, DC bar member
DATE SIGNED 02/12/2021
SIGNATORY'S PHONE NUMBER 202-258-0652
SIGNATURE METHOD Signed directly within the form
FILING INFORMATION
SUBMIT DATE Fri Feb 12 18:12:08 ET 2021
TEAS STAMP USPTO/ESU-XXX.XX.XXX.XX-2
0210212181208433580-88056
364-760aa1fed5550f29ff6b4
d47f44b88843c6fd629c10199
a81165de9c586f06b79-CC-12
054997-202102121810024192
37



PTO- 1581
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: BASILEA LABS (see, http://uspto.report/TM/88056364/mark.png)
SERIAL NUMBER: 88056364

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Basilea Pharmaceutica AG, having an address of
      Grenzacherstrasse 487
      Basel, 4058
      Switzerland
      Email: XXXX
Proposed: Basilea Pharmaceutica AG, having an address of
      Grenzacherstrasse 487
      Basel, 4058
      Switzerland
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 09/03/2019.

For International Class 001:
Current identification: Diagnostic preparations for clinical or medical laboratory use; Diagnostic reagents for clinical or medical laboratory use

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 005:
Current identification: Pharmaceutical and veterinary preparations for the treatment or prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary preparations for the treatment of infections caused by bacteria, fungi, viruses and rheumatoid arthritis; Pharmaceutical and veterinary preparations for the treatment of diseases, disorders and conditions in the area of oncology

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Evan A. Raynes
      PRIMARY EMAIL FOR CORRESPONDENCE: eraynes@symbus.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): legalasst@symbus.com

Correspondence Information (proposed):
      Evan A. Raynes
      PRIMARY EMAIL FOR CORRESPONDENCE: eraynes@symbus.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kflanagan@symbus.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Evan A. Raynes/      Date Signed: 02/12/2021
Signatory's Name: Evan A. Raynes
Signatory's Position: Attorney of record, DC bar member
Signatory's Phone: 202-258-0652
Signature method: Signed directly within the form

PAYMENT: 88056364
PAYMENT DATE: 02/12/2021

Serial Number: 88056364
Internet Transmission Date: Fri Feb 12 18:12:08 ET 2021
TEAS Stamp: USPTO/ESU-XXX.XX.XXX.XX-2021021218120843
3580-88056364-760aa1fed5550f29ff6b4d47f4
4b88843c6fd629c10199a81165de9c586f06b79-
CC-12054997-20210212181002419237




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed